Eirik Viste, Cathrine Alvaer Vinje, Torgeir Gilje Lid, Svein Skeie, Øystein Evjen-Olsen, Tobias Nordström, . . . Svein R. Kjosavik. (2020). Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system - the Stavanger experience. Taylor & Francis Group.
Chicago Style (17th ed.) CitationEirik Viste, et al. Effects of Replacing PSA with Stockholm3 for Diagnosis of Clinically Significant Prostate Cancer in a Healthcare System - the Stavanger Experience. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationEirik Viste, et al. Effects of Replacing PSA with Stockholm3 for Diagnosis of Clinically Significant Prostate Cancer in a Healthcare System - the Stavanger Experience. Taylor & Francis Group, 2020.
Warning: These citations may not always be 100% accurate.